Operating Profit and Market Capitalization Targets under Performance-Linked Stock Acquisition Rights for Directors
First written in FY2024-Q3. 2 of 5 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2020: 2 of 10 companies on the "Worse" side.
4 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「After vesting (shares) End of previous consolidated fiscal year - Vested 692,400 Exercised - Forfeited - Outstanding and unexercised 692,400」
For the ninth series of stock acquisition rights for directors, rights equivalent to 692,400 shares vested and were recorded as outstanding and unexercised. - 2026-05-15AdvancedRevision to earnings forecast
「As our share price remained firm, the likelihood increased that the market capitalization condition for exercising the stock acquisition rights, ¥10 billion, would be reached.」
The likelihood of reaching the ¥10 billion market capitalization condition for exercising the stock acquisition rights increased, and ¥37 million of share-based compensation expense was recorded. Achievement of the target has not been confirmed. - FY2025RestatedAnnual report
「If market capitalization exceeds ¥3.5 billion at least once and operating profit exceeds ¥120 million at least once: exercisable percentage, 35%. If market capitalization exceeds ¥10 billion at least once and operating profit exceeds ¥120 million at least once: exercisable percentage, 100%.」
The company continues to disclose exercise conditions for directors’ stock acquisition rights based on operating profit of ¥120 million and market capitalization of either ¥3.5 billion or ¥10 billion. Following the stock split, the number of underlying shares is 659,800 and the exercise price is ¥414. - FY2024RestatedAnnual report
「If market capitalization exceeds ¥3.5 billion at least once and operating profit exceeds ¥120 million at least once: exercisable percentage, 35%. If market capitalization exceeds ¥10 billion at least once and operating profit exceeds ¥120 million at least once: exercisable percentage, 100%.」
The annual disclosure confirms that the exercise conditions for stock acquisition rights for directors are operating profit of ¥120 million and market capitalization of either ¥3.5 billion or ¥10 billion, to be achieved during the period from the fiscal year ending March 2025 through the fiscal year ending March 2027. - FY2024-Q3First statedAnnual report
「At a meeting of the Board of Directors held on 20 December 2023, we resolved to issue stock acquisition rights to our directors, referred to below as these stock acquisition rights, and issued them on 24 January 2024. Exercise period for the stock acquisition rights: 24 January 2026 to 23 January 2029. The exercise conditions for the stock acquisition rights are as follows. Holders of the allocated stock acquisition rights may exercise 35% if, in any 1 of the 3 fiscal years from the fiscal year ending March 2025 through the fiscal year ending March 2027, market capitalization exceeds ¥3.5 billion at least once and operating profit exceeds ¥120 million at least once; and may exercise 100% if market capitalization exceeds ¥10 billion at least once and operating profit exceeds ¥120 million at least once.」
Issued 3,299 stock acquisition rights, representing 329,900 underlying shares, to 7 directors. The exercise conditions for any fiscal year from the fiscal year ending March 2025 through the fiscal year ending March 2027 were set at operating profit of ¥120 million and market capitalization of either ¥3.5 billion or ¥10 billion, with exercisable percentages of 35% or 100% depending on the level achieved.